EndeavorOTC® Research Study in College Students

Cognition Clinical Trial

Official title:

EndeavorOTC® Research Study in College Students

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06376032
• Other study ID #: Akili-068
• Status: Recruiting
• Phase: N/A
• Start date: January 10, 2024
• Est. completion date: December 31, 2025

Study information

• Verified date: April 2024
• Source: Akili Interactive Labs, Inc.
• Contact: Minny Suh, MS
• Phone: 857-254-4444
• Email: minny[@]akiliinteractive.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The objective of this study is to evaluate the impact of a digital therapeutic (EndeavorOTC®, also known as AKL-T01A) on clinical symptoms of executive and cognitive functioning in a real-world sample of university students. This study aims to answer whether EndeavorOTC represents a useful intervention for targeting broad cognitive and emotional health among university students.

Description:

University students face an increased risk of mental health challenges, as well as elevated stress due to the demands of managing coursework and social stress during a formative developmental period with increased independence. Consequently, there is a need for scalable, evidence-based interventions that can help university students manage their cognitive and emotional health. Through a partnership between Akili Interactive Labs and participating colleges, free 12-week access to AKL-T01 will be provided to any student interested in treatment for the duration of an academic semester, up to an N of 500 per site. This study will evaluate changes in participants across a range of clinical and functional outcomes, including cognitive functioning, academic outcomes, social functioning, attention and associated symptoms, and quality of life. The study will also evaluate user feedback and information on the usability of AKL-T01 through both quantitative and qualitative methods.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 500
• Est. completion date: December 31, 2025
• Est. primary completion date: December 31, 2025
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Owns a personal Android or iOS device to access AKL-T01 treatment

• Provides informed consent to participate in this study

• Is 18 years of age or older

Exclusion Criteria:

• Known photosensitive epilepsy, color blindness, and any physical limitation that would make engagement with an app-based digital intervention difficult

• Has participated in the same study in previous semesters

Pregnant and nursing people are eligible to participate.

Related Conditions & MeSH terms

• Attention
• Cognition
• University Students

Intervention

Device:
• EndeavorOTC®
EndeavorOTC is an over the counter digital therapeutic designed to improve attention function as measured by computer-based testing in patients 18 and older with primarily inattentive or combined type ADHD, who have a demonstrated attention issue. EndeavorOTC utilizes the same proprietary technology underlying EndeavorRx®, an FDA-authorized prescription digital therapeutic indicated to improve attention function in children ages 8-17. EndeavorOTC is deployed on mobile devices and incorporates adaptive, simultaneous cognitive tasks in a consumer-grade action videogame-based platform with high-quality graphics and reward mechanisms.

Locations

Country	Name	City	State
United States	Villa Maria College	Cheektowaga	New York
United States	Landmark College	Putney	Vermont

Sponsors (3)

Lead Sponsor	Collaborator
Akili Interactive Labs, Inc.	Landmark College, Villa Maria College

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	System Usability Scale (SUS)	The SUS is a brief, validated 10-item questionnaire that is designed to evaluate a wide variety of products and services, including hardware, software, mobile devices, websites and applications.22 The SUS consists of 10 items rated on a 5-point Likert scale that range from "strongly agree" to "strongly disagree." Results interpretation typically requires normalizing the scores to produce a percentile ranking; however, a SUS score above 68 can generally be considered above average, and a score below 68, generally considered below average.	Day 84
Primary	Computerized Adaptive Test, Mental Health (CAT-MH®)	Computerized Adaptive Test, Mental Health (CAT-MH®) is a distinct suite of computer adaptive tests that is based on multidimensional item response theory. The adult ADHD module is a dimensional severity measure of attention-deficit/hyperactivity disorder symptomatology for adults 18 and over. The number and selection of questions within the assessment varies as individuals' initial item responses are used to determine a provisional estimate of their standing on the measured trait to be used for subsequent item selection. Items are scored on a Likert scale of 1 (Not at all), 2 (Just a little), 3 (Somewhat), 4 (Quite a bit), and 5 (Very much).; Negative change in score indicates improvement in ADHD severity.	Baseline, Exit (Day 84)
Primary	PROMIS Cognitive Function v2.0 - Short Form	The PROMIS Cognitive Function v2.0 short form consists of six questions about the respondent's cognitive function in the past 7 days rated on a Likert scale of 1-5, where 1=Very often (Several times a day) and 5=Never.; Higher score indicates higher levels of cognition. Positive change in score indicates improvement.	Baseline, Day 42, Day 84
Primary	PROMIS Satisfaction with Participation in Discretionary Social Activities (v1.0)	The PROMIS Satisfaction with Participation in Discretionary Social Activities scale consists of 7 questions about the respondent's satisfaction in the past 7 days rated on a Likert scale of 1-5 where 1=Not at all and 5=Very much.; Higher score indicates more satisfaction. Positive change in score indicates improvement.	Baseline, Day 42, Day 84
Primary	General Academic Self-Efficacy scale (GASE)	The GASE is a short and concise five-item measure of the longer form Academic self-efficacy (ASE) scale. The scale assesses a student's global belief in his or her ability to master the various academic challenges in an academic setting and is considered an essential antecedent of wellbeing and performance.; Higher score indicates more self-efficacy. Positive change in score indicates improvement.	Baseline, Day 42, Day 84
Primary	Mental Health Quality of Life Scale (MHQoL)	The MHQoL is a standardized, validated self-report measure of quality of life that has been developed for use in people with mental health problems.18 It consists of 7-items covering self-image, independence, mood, relationships, daily activities, physical health, and future measured on a 4-point Likert scale ranging from "Very satisfied" to "Very dissatisfied," and an analogue scale from regarding psychological well-being where 0 = "worst imaginable psychological well-being" and 10 = "best imaginable psychological well-being."; Higher score indicates a better quality of life. Positive change in score indicates improvement.	Baseline, Day 42, Day 84
Primary	Adult ADHD Self-Report Scale (ASRS)	The ASRS v1.1 is an 18-item self-report validated questionnaire designed to assess ADHD symptoms in adults. No total score or diagnostic likelihood is utilized for the twelve questions. Frequency scores are used to determine if the patient has symptoms highly consistent with ADHD in adults. The frequency-based response is more sensitive with certain questions.; Greater frequency indicates higher symptom consistency with ADHD in adults. Negative change indicates improvement.	Baseline, Day 42, Day 84
Primary	Patient Health Questionnaire-4 (PHQ-4)	PHQ-4 is an ultra-brief, validated screening assessment for anxiety and depression, consisting of four-items that are scored on a Likert scale of 0 (not at all), 1 (several days), 2 (more than half the days), and 3 (nearly every day).; A higher score indicates greater levels of depression and anxiety. Negative change indicates improvement.	Baseline, Day 42, Day 84